Selerant Takes a Bigger Bite Out of the Big Apple; Selerant Moves US Operations to Manhattan, New York
NEW YORK, Feb. 17 /PRNewswire/ -- Selerant (www.selerant.com) announces its move to Manhattan, New York, effective February 19, 2010.
"We are extremely pleased to not only offer our clients a more convenient location in midtown Manhattan," explains Selerant CEO, Carlo Colombo, "but we can also provide state-of-the-art technology on-site with enhanced security and even greater room to grow for the future."
Selerant's clients include several Fortune 500 companies who utilize DevEX, their web-based Product Lifecycle Management (PLM) software solution to expedite products from concept to market.
Selerant's new offices are located at 499 7th Avenue, Suite 18N, New York, NY 10018.
About Selerant
Founded in 1990, Selerant Corporation focuses solely on formula-based product development software to expedite time to market, ensure quality and regulatory compliance, improve product quality, and build lasting relationships with their customers.
Earning the prestigious ISO-9001: 2000 certification for best practices, as well as successfully achieving FDA 21CFR PART II compliance implementation, Selerant provides exceptional service and solutions for over 500 companies and global mid-sized organizations. With a global presence and over 300 cumulative years of experience, Selerant offers unique expertise to serve leaders in process manufacturing industries, including: food, beverage, flavor, chemicals, paint, ink, fragrance, household goods, pharmaceuticals, and cosmetics.
Learn more at www.selerant.com
Contact: Michelle Duerst |
|
Selerant |
|
718-260-8037 |
|
This release was issued through The Xpress Press News Service, merging e-mail and satellite distribution technologies to reach business analysts and media outlets worldwide. For more information, visit http://www.XpressPress.com
SOURCE Selerant
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article